It has been proven to drastically decrease the chances of contracting HIV before one is even exposed to the virus: Truvada is considered a medical breakthrough by some, yet others fear the once-a-day prevention pill could spur a deadly AIDS epidemic. The drug — a small, blue pill ingested orally — is currently awaiting FDA approval. Its manufacturer, Gilead, argues that Truvada would reduce the... 

The Food and Drug Administration has approved a once-per-day HIV treatment that combines its Gilead Sciences Inc.’s drug Truvada with Johnson & Johnson’s drug Edurant, Gilead said Wednesday. The combination pill is called Complera, and it is approved for patients who have not previously been treated for HIV. Gilead’s drug Truvada is a combination pill containing the drugs emtracitabine...